Kymera Therapeutics

Showing 1 posts of 1 posts found.


Kymera Therapeutics reports positive data in cancer drug trials

June 14, 2023
Research and Development Cancer, Kymera Therapeutics, Oncology, autoimmune diseases, clinical trials, inflammatory diseases

US clinical-stage biopharmaceutical company Kymera Therapeutics has shared new data regarding its oncology programmes KT-333 and KT-413, highlighting their robust dose-dependent …

Latest content